On the contrary, decreased levels of GH/IGF-I promote the development of NAFLD, and supplementation of recombinant GH in individuals with GH deficiency reversed hepatic steatosis (4, 5). The gene discussed is IGF1; the disease is metabolic dysfunction-associated steatotic liver disease.